548 related articles for article (PubMed ID: 26844829)
1. Axon Self-Destruction: New Links among SARM1, MAPKs, and NAD+ Metabolism.
Gerdts J; Summers DW; Milbrandt J; DiAntonio A
Neuron; 2016 Feb; 89(3):449-60. PubMed ID: 26844829
[TBL] [Abstract][Full Text] [Related]
2. SARM1 activation triggers axon degeneration locally via NAD⁺ destruction.
Gerdts J; Brace EJ; Sasaki Y; DiAntonio A; Milbrandt J
Science; 2015 Apr; 348(6233):453-7. PubMed ID: 25908823
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial impairment activates the Wallerian pathway through depletion of NMNAT2 leading to SARM1-dependent axon degeneration.
Loreto A; Hill CS; Hewitt VL; Orsomando G; Angeletti C; Gilley J; Lucci C; Sanchez-Martinez A; Whitworth AJ; Conforti L; Dajas-Bailador F; Coleman MP
Neurobiol Dis; 2020 Feb; 134():104678. PubMed ID: 31740269
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of NAMPT or MAPK inhibitors and NaR on Wallerian degeneration of mammalian axons.
Alexandris AS; Ryu J; Rajbhandari L; Harlan R; McKenney J; Wang Y; Aja S; Graham D; Venkatesan A; Koliatsos VE
Neurobiol Dis; 2022 Sep; 171():105808. PubMed ID: 35779777
[TBL] [Abstract][Full Text] [Related]
5. The SARM1 axon degeneration pathway: control of the NAD
Figley MD; DiAntonio A
Curr Opin Neurobiol; 2020 Aug; 63():59-66. PubMed ID: 32311648
[TBL] [Abstract][Full Text] [Related]
6. The chemical biology of NAD
Icso JD; Thompson PR
Curr Opin Chem Biol; 2022 Aug; 69():102176. PubMed ID: 35780654
[TBL] [Abstract][Full Text] [Related]
7. SARM1 can be a potential therapeutic target for spinal cord injury.
Lu Q; Botchway BOA; Zhang Y; Jin T; Liu X
Cell Mol Life Sci; 2022 Feb; 79(3):161. PubMed ID: 35224705
[TBL] [Abstract][Full Text] [Related]
8. Programmed axon degeneration: from mouse to mechanism to medicine.
Coleman MP; Höke A
Nat Rev Neurosci; 2020 Apr; 21(4):183-196. PubMed ID: 32152523
[TBL] [Abstract][Full Text] [Related]
9. Wallerian degeneration: an emerging axon death pathway linking injury and disease.
Conforti L; Gilley J; Coleman MP
Nat Rev Neurosci; 2014 Jun; 15(6):394-409. PubMed ID: 24840802
[TBL] [Abstract][Full Text] [Related]
10. Axon Death Pathways Converge on Axundead to Promote Functional and Structural Axon Disassembly.
Neukomm LJ; Burdett TC; Seeds AM; Hampel S; Coutinho-Budd JC; Farley JE; Wong J; Karadeniz YB; Osterloh JM; Sheehan AE; Freeman MR
Neuron; 2017 Jul; 95(1):78-91.e5. PubMed ID: 28683272
[TBL] [Abstract][Full Text] [Related]
11. SARM1 is a metabolic sensor activated by an increased NMN/NAD
Figley MD; Gu W; Nanson JD; Shi Y; Sasaki Y; Cunnea K; Malde AK; Jia X; Luo Z; Saikot FK; Mosaiab T; Masic V; Holt S; Hartley-Tassell L; McGuinness HY; Manik MK; Bosanac T; Landsberg MJ; Kerry PS; Mobli M; Hughes RO; Milbrandt J; Kobe B; DiAntonio A; Ve T
Neuron; 2021 Apr; 109(7):1118-1136.e11. PubMed ID: 33657413
[TBL] [Abstract][Full Text] [Related]
12. MAPK signaling promotes axonal degeneration by speeding the turnover of the axonal maintenance factor NMNAT2.
Walker LJ; Summers DW; Sasaki Y; Brace EJ; Milbrandt J; DiAntonio A
Elife; 2017 Jan; 6():. PubMed ID: 28095293
[TBL] [Abstract][Full Text] [Related]
13. DLK Activation Synergizes with Mitochondrial Dysfunction to Downregulate Axon Survival Factors and Promote SARM1-Dependent Axon Degeneration.
Summers DW; Frey E; Walker LJ; Milbrandt J; DiAntonio A
Mol Neurobiol; 2020 Feb; 57(2):1146-1158. PubMed ID: 31696428
[TBL] [Abstract][Full Text] [Related]
14. NMNAT1 inhibits axon degeneration via blockade of SARM1-mediated NAD
Sasaki Y; Nakagawa T; Mao X; DiAntonio A; Milbrandt J
Elife; 2016 Oct; 5():. PubMed ID: 27735788
[TBL] [Abstract][Full Text] [Related]
15. Palmitoylation enables MAPK-dependent proteostasis of axon survival factors.
Summers DW; Milbrandt J; DiAntonio A
Proc Natl Acad Sci U S A; 2018 Sep; 115(37):E8746-E8754. PubMed ID: 30150401
[TBL] [Abstract][Full Text] [Related]
16. Sarm1 Deletion, but Not Wld
Gilley J; Ribchester RR; Coleman MP
Cell Rep; 2017 Oct; 21(1):10-16. PubMed ID: 28978465
[TBL] [Abstract][Full Text] [Related]
17. Vincristine and bortezomib use distinct upstream mechanisms to activate a common SARM1-dependent axon degeneration program.
Geisler S; Doan RA; Cheng GC; Cetinkaya-Fisgin A; Huang SX; Höke A; Milbrandt J; DiAntonio A
JCI Insight; 2019 Sep; 4(17):. PubMed ID: 31484833
[TBL] [Abstract][Full Text] [Related]
18. Absence of SARM1 rescues development and survival of NMNAT2-deficient axons.
Gilley J; Orsomando G; Nascimento-Ferreira I; Coleman MP
Cell Rep; 2015 Mar; 10(12):1974-81. PubMed ID: 25818290
[TBL] [Abstract][Full Text] [Related]
19. Sarm1 haploinsufficiency or low expression levels after antisense oligonucleotides delay programmed axon degeneration.
Gould SA; Gilley J; Ling K; Jafar-Nejad P; Rigo F; Coleman M
Cell Rep; 2021 Dec; 37(11):110108. PubMed ID: 34910914
[TBL] [Abstract][Full Text] [Related]
20. SARM1 acts downstream of neuroinflammatory and necroptotic signaling to induce axon degeneration.
Ko KW; Milbrandt J; DiAntonio A
J Cell Biol; 2020 Aug; 219(8):. PubMed ID: 32609299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
